Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns ...

Makary has been a prominent voice on U.S. health care practices whose research focuses on the underlying causes of disease, ...

Hims & Hers Health Inc. shares surged as much as 18% and are on track to close at fresh record after Hunterbrook Media said the company is poised to be a major beneficiary of President-elect Donald ...

Maryland scholars on Monday alternately described President-elect Donald Trump’s pick to lead the U.S. Food and Drug ...

After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.

Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...

The public-health establishment and left-wing media are rushing to discredit President-elect Donald Trump’s picks to lead ...

Hims & Hers Health Inc. shares surged as much ... major beneficiary of President-elect Donald Trump’s nomination of Marty Makary to lead the Food and Drug Administration. Hunterbrook said ...

Hunterbrook Capital said today it is long Hims & Hers Health. The company may soon have a key ally in the Trump administration in Dr. Marty Makary, an executive of a startup called Sesame ...